If you're looking for oncotypeiq.com.com's Adword's Competitors iSpionage Competitor Research is the right product for you
Top Competitors for oncotypeiq.com
| PPC Budget | # Keywords | # Overlap kw | ||
|---|---|---|---|---|
| prescriptiontreatmentwebsite | $784,154 | 110,530 | 29 | Learn More |
| mybreastcancertreatment.org | $577 | 609 | 24 | Learn More |
| color.com | $942 | 562 | 12 | Learn More |
| mdanderson.org | $7,947 | 4,305 | 10 | Learn More |
| nyp.org | $5,882 | 3,848 | 9 | Learn More |
Competitor offers & landing pages
Sample SEO Keywords for: oncotypeiq.com
Organic Listings | 1st Page Keywords | Avg Pos | Pos Trend | Est.Traffic | Traffic Value | |
|---|---|---|---|---|---|---|
[PDF]Patient Guide to Early-Stage Invasive Breast Cancer ... - Oncotype DX http://www.oncotypeiq.com/-/meInvasive Breast. Cancer Surger | 3 | 15 ( 4 ) | 1310 | $0 | ||
| Keyword | Position | Trend | Search Vol | CPC | ||
| invasive ductal carcinoma grade 2 treatment | 11 | 20 | $2.84 | |||
| stage 1 grade 3 breast cancer | 12 ( 4 ) | 70 | $3.48 | |||
| stage 1 invasive breast cancer | 12.5 | 30 | $9.75 | |||
| treatment for invasive breast cancer | 14 | 10 | $10.49 | |||
| early stage of breast cancer | 15 | 50 | $2.15 | |||
About the Oncotype DX Breast Recurrence Score® | Oncotype IQ® https://www.oncotypeiq.com/en-Information for patients with | 1 | 14 | 210 | $0 | ||
| Keyword | Position | Trend | Search Vol | CPC | ||
| dx testing | 5 | 20 | $2.92 | |||
| dx test | 6 ( 1 ) | 40 | $1.71 | |||
| breast cancer oncotype | 7 | 40 | $12.29 | |||
| onco type dx | 2 | 40 | $2.71 | |||
| oncotype dx breast cancer | 7 | 70 | $7.92 | |||
Sample PPC Keywords for: oncotypeiq.com
Top Ads
Order Oncotype DX® Predictive and Prognostic Results You Can Count On. Learn More. Clinically-validated. Standard of care. www.oncotypeiq.com/OncotypeDX New Oncotype DX® Report It's never been as clear to predict chemotherapy benefit. See a sample report. Predictive and prognostic. Standard of care. Clinically-validated. www.oncotypeiq.com/OncotypeDX Oncotype DX® | Genomic Prostate Test | oncotypeiq.com Validated as strong, independent predictor of adverse pathology at prostatectomy. Risk of Adverse Pathology. Increased AS Utilization. www.oncotypeiq.com/OncotypeDX/ProstateScore Order Oncotype DX® Predictive and Prognostic Results You Can Count On. Learn More. Standard of care. Clinically-validated. www.oncotypeiq.com/OncotypeDX | |||
New Oncotype DX® Report Predictive and Prognostic Results You Can Count On. Learn More. Clinically-validated. Standard of care. www.oncotypeiq.com/OncotypeDX Oncotype DX® | Genomic Prostate Score Validated as strong, independent predictor of adverse pathology at prostatectomy. Increased AS Utilization. Risk of Adverse Pathology. www.oncotypeiq.com/OncotypeDX/ProstateScore Active Surveillance | Genomic Prostate Score Validated as strong, independent predictor of adverse pathology at prostatectomy. Increased AS Utilization. Risk of Adverse Pathology. www.oncotypeiq.com/OncotypeDX/ProstateScore Oncotype DX Recurrence Score® | See How Clear Results Can Be It's never been as clear to predict chemotherapy benefit. See a sample report. www.oncotypeiq.com/OncotypeDX | |||
Order Oncotype DX® Predictive and Prognostic Results You Can Count On. Learn More. Standard of care. www.oncotypeiq.com/OncotypeDX Oncotype DX® - Official Site - Breast Recurrence Score® Predictive and Prognostic Results You Can Count On. Learn More. Standard of care. www.oncotypeiq.com/OncotypeDX Count on Oncotype DX® AR-V7 - AR-V7 Nucleus Detect Assay Rapidly determine the next step in treatment for your patients with mCRPC. A Liquid Biopsy Test. First Predictive Test. www.oncotypeiq.com/AR-V7 New Oncotype DX® Report Predictive and Prognostic Results You Can Count On. Learn More. www.oncotypeiq.com/OncotypeDX | |||
GPS Report Tool Validated as strong, independent predictor of adverse pathology at prostatectomy. Increased AS Utilization. Risk of Adverse Pathology. www.oncotypeiq.com/OncotypeDX/ProstateScore Oncotype DX® - Official Site - Breast Recurrence Score® Predictive and Prognostic Results You Can Count On. Learn More. Clinically-validated. Standard of care. www.oncotypeiq.com/OncotypeDX Count on Oncotype DX® | All Assays Are Not the Same More than Prognostic-Only: Predicts Magnitude of Chemo Benefit. Learn More. Clinically-validated. Standard of care. Predictive and prognostic. Highlights: Secure Web-Based Platform, CLIA-Certified Lab www.oncotypeiq.com/OncotypeDX Count on Oncotype DX® | Genomic Prostate Score | oncotypeiq.com Established to provide an actionable result for confident treatment decisions. Clinically-validated. www.oncotypeiq.com/OncotypeDX/ProstateScore | |||
New Oncotype DX® Report Predictive and Prognostic Results You Can Count On. Learn More. Standard of care. www.oncotypeiq.com/OncotypeDX New Oncotype DX® Report Predictive and Prognostic Results You Can Count On. Learn More. Clinically-validated. www.oncotypeiq.com/OncotypeDX Prostate Cancer Tumor Biology | Prostate Cancer Genomics Certain genes are predictive of adverse pathology. Learn about Oncotype DX. www.oncotypeiq.com/OncotypeDX/ProstateScore Oncotype DX® | Genomic Prostate Score Get Information on How to Interpret Results. View Sample Report. Learn More. Clinically-validated. www.oncotypeiq.com/OncotypeDX/ProstateScore | |||
Oncotype DX® - Breast Recurrence Score® Predictive and Prognostic Results You Can Count On. Learn More. Standard of care. Clinically-validated. www.oncotypeiq.com/OncotypeDX New Oncotype DX® Report It's never been as clear to predict chemotherapy benefit. See a sample report. Clinically-validated. Predictive and prognostic. Standard of care. www.oncotypeiq.com/OncotypeDX Active Surveillance | Genomic Prostate Score Validated as strong, independent predictor of adverse pathology at prostatectomy. Increased AS Utilization. Risk of Adverse Pathology. Highlights: Offering Secure Web-Based Platform, Provider Of Genom www.oncotypeiq.com/OncotypeDX/ProstateScore AR-V7 Nucleus Detect Assay - Count on Oncotype DX® The only predictive and prognostic test for patients with mCRPC. Learn more. A Liquid Biopsy Test. www.oncotypeiq.com/AR-V7 | |||
Ordering The Test Rapidly determine the next step in treatment for your patients with mCRPC. First Predictive Test. www.oncotypeiq.com/AR-V7 Oncotype DX® - Breast Recurrence Score® Predictive and Prognostic Results You Can Count On. Learn More. Clinically-validated. Standard of care. www.oncotypeiq.com/OncotypeDX Oncotype DX® - Official Site - Breast Recurrence Score® Predictive and Prognostic Results You Can Count On. Learn More. Clinically-validated. www.oncotypeiq.com/OncotypeDX AR-V7 Nucleus Detect Assay - Count on Oncotype DX® Rapidly determine the next step in treatment for your patients with mCRPC. First Predictive Test. A Liquid Biopsy Test. www.oncotypeiq.com/AR-V7 | |||
Oncotype DX® | Genomic Prostate Test Validated as strong, independent predictor of adverse pathology at prostatectomy www.oncotypeiq.com/ Count on Oncotype DX® | Genomic Prostate Test Established to provide an actionable result for confident treatment decisions. Increased AS Utilization. Risk of Adverse Pathology. www.oncotypeiq.com/ Order Oncotype DX® It's never been as clear to predict chemotherapy benefit. See a sample report. Standard of care. Clinically-validated. Predictive and prognostic. www.oncotypeiq.com/ TAILORx Study Results Predictive and Prognostic Results You Can Count On. Learn More. Clinically-validated. Standard of care. www.oncotypeiq.com/OncotypeDX | |||
Oncotype DX® - Official Site | TAILORx Results Published The largest adjuvant breast cancer treatment trial ever conducted. Learn More. Clinically-validated. Predictive and prognostic. Standard of care. Highlights: Provider Of Genomic-Based Diagnostic Tests www.oncotypeiq.com/ Count on Oncotype DX® | All Assays Are Not the Same More than Prognostic-Only: Predicts Magnitude of Chemo Benefit. Learn More. Standard of care. Predictive and prognostic. Clinically-validated. Highlights: Secure Web-Based Platform, CLIA-Certified Lab www.oncotypeiq.com/OncotypeDX Oncotype DX® | Genomic Prostate Score Confidently recommend active surveillance or immediate treatment. Learn more. Clinically-validated. www.oncotypeiq.com/OncotypeDX/ProstateScore AR-V7 Nucleus Detect Assay - Count on Oncotype DX® The only predictive and prognostic test for patients with mCRPC. Learn more. First Predictive Test. www.oncotypeiq.com/AR-V7 | |||
TAILORx Study Results Predictive and Prognostic Results You Can Count On. Learn More. Clinically-validated. www.oncotypeiq.com/OncotypeDX Oncotype DX® | Genomic Prostate Test Validated as strong, independent predictor of adverse pathology at prostatectomy. Risk of Adverse Pathology. Increased AS Utilization. Highlights: Offering Secure Web-Based Platform, Provider Of Genom www.oncotypeiq.com/OncotypeDX/ProstateScore Oncotype DX® | Genomic Prostate Score | oncotypeiq.com Confidently recommend active surveillance or immediate treatment. Learn more. Clinically-validated. www.oncotypeiq.com/OncotypeDX/ProstateScore Count on Oncotype DX® - Comprehensive 21-Gene Assay The Only Assay Validated for Prediction of Adjuvant Therapy Benefit & Prognosis. Standard of care. Predictive and prognostic. Clinically-validated. www.oncotypeiq.com/OncotypeDX | |||
